All In MedTech

FDA Clearance Tracker · P990025

NAVI-STAR DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jun 15, 2000 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Jun 15, 2000

Approved

Time to decision

388 days

Received May 24, 1999. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class II

The decision

FDA number
P990025
Device name
NAVI-STAR DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER
Applicant location
Irvine, CA
Received
May 24, 1999
Decided
Jun 15, 2000
Decision
Approved
Supplements
72 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class II
Regulation
21 CFR 870.1220
Specialty
Cardiology

Every decision under product code DRF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE NAVI-STAR(R) DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER. THE NAVI-STAR DIAGNOSTIC/ABLATION CATHETER, AND RELATED ACCESSORY DEVICES ARE INDICATED FOR CATHETER-BASED ATRIAL AND VENTRICULAR CARDIAC MAPPING, AND WHEN USED WITH A COMPATIBLE RADIO FREQUENCY GENERATOR IN ADULTS AND CHILDREN 4 YEARS OF AGE AND OLDER FOR:* INTERRUPTION OF ACCESSORY ATRIOVENTRICULAR (AV) CONDUCTION PATHWAYS ASSOCIATED WITH TACHYCARDIA; INCLUDING PERSISTEND JUNCTIONAL RE-ENTRANT TACHYCARDIA (PJRT) ...

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code DRF. The earliest in FDA's data is K770341, decided Feb 28, 1977.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Biosense Webster, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.